OBGIX
Price
$30.49
Change
+$0.12 (+0.40%)
Updated
Dec 20 closing price
SMCWX
Price
$67.91
Change
-$0.02 (-0.03%)
Updated
Dec 20 closing price
Ad is loading...

OBGIX vs SMCWX

Header iconOBGIX vs SMCWX Comparison
Open Charts OBGIX vs SMCWXBanner chart's image
Oberweis Global Opportunities Instl
Price$30.49
Change+$0.12 (+0.40%)
VolumeN/A
CapitalizationN/A
American Funds SMALLCAP World A
Price$67.91
Change-$0.02 (-0.03%)
VolumeN/A
CapitalizationN/A
OBGIX vs SMCWX Comparison Chart
Loading...
View a ticker or compare two or three
VS
OBGIX vs. SMCWX commentary
Dec 22, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is OBGIX is a Hold and SMCWX is a Buy.

FUNDAMENTALS
Fundamentals
SMCWX has more cash in the bank: 73.6B vs. OBGIX (57.9M). SMCWX pays higher dividends than OBGIX: SMCWX (0.61) vs OBGIX (0.00). OBGIX was incepted earlier than SMCWX: OBGIX (8 years) vs SMCWX (35 years). OBGIX is a more actively managed with annual turnover of: 95.00 vs. SMCWX (29.00). SMCWX has a lower initial minimum investment than OBGIX: SMCWX (250) vs OBGIX (1000000). OBGIX annual gain was more profitable for investors over the last year : 12.05 vs. SMCWX (4.27). OBGIX return over 5 years is better than : 22.70 vs. SMCWX (12.92).
OBGIXSMCWXOBGIX / SMCWX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence8 years35 years-
Gain YTD11.4813.117368%
Front LoadN/AN/A-
Min. Initial Investment1000000250400,000%
Min. Initial Investment IRAN/AN/A-
Net Assets57.9M73.6B0%
Annual Yield % from dividends0.000.61-
Returns for 1 year12.054.27283%
Returns for 3 years-29.34-11.74250%
Returns for 5 years22.7012.92176%
Returns for 10 yearsN/A38.25-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RDFN8.520.45
+5.58%
Redfin Corp
BCBP12.070.34
+2.90%
BCB Bancorp
TRU95.112.16
+2.32%
TransUnion
FHI41.050.28
+0.69%
Federated Hermes
PMCB1.64N/A
N/A
PharmaCyte Biotech